Sandra Cantilena

417 total citations
12 papers, 309 citations indexed

About

Sandra Cantilena is a scholar working on Molecular Biology, Neurology and Oncology. According to data from OpenAlex, Sandra Cantilena has authored 12 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Neurology and 4 papers in Oncology. Recurrent topics in Sandra Cantilena's work include Neuroblastoma Research and Treatments (5 papers), Protein Degradation and Inhibitors (3 papers) and Acute Myeloid Leukemia Research (2 papers). Sandra Cantilena is often cited by papers focused on Neuroblastoma Research and Treatments (5 papers), Protein Degradation and Inhibitors (3 papers) and Acute Myeloid Leukemia Research (2 papers). Sandra Cantilena collaborates with scholars based in United Kingdom, Italy and Australia. Sandra Cantilena's co-authors include Arturo Sala, Olesya Chayka, Izabela Piotrowska, Daisy Corvetta, Fabio Pastorino, Mirco Ponzoni, Annalisa Pezzolo, Vito Pistoia, John Anderson and Cosimo Walter D’Acunto and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Clinical Cancer Research.

In The Last Decade

Sandra Cantilena

12 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Cantilena United Kingdom 9 202 111 87 65 55 12 309
Katya Nardou Switzerland 8 255 1.3× 102 0.9× 114 1.3× 83 1.3× 29 0.5× 10 366
Hexiu Su China 8 281 1.4× 58 0.5× 107 1.2× 124 1.9× 20 0.4× 11 383
Guolin Chai China 6 377 1.9× 39 0.4× 110 1.3× 81 1.2× 25 0.5× 9 464
Dora Ling Australia 8 266 1.3× 60 0.5× 37 0.4× 123 1.9× 22 0.4× 8 357
Lintong Li China 2 181 0.9× 76 0.7× 127 1.5× 38 0.6× 19 0.3× 4 292
Namrata Bhatnagar United States 5 270 1.3× 79 0.7× 94 1.1× 187 2.9× 45 0.8× 6 397
Bingwei Ye United States 9 250 1.2× 63 0.6× 39 0.4× 162 2.5× 18 0.3× 12 349
Cristina Zahonero Spain 6 174 0.9× 29 0.3× 66 0.8× 55 0.8× 28 0.5× 7 318
Margherita Galletti Italy 8 177 0.9× 23 0.2× 66 0.8× 44 0.7× 145 2.6× 9 343
Junyi Yin China 7 147 0.7× 28 0.3× 50 0.6× 90 1.4× 58 1.1× 8 254

Countries citing papers authored by Sandra Cantilena

Since Specialization
Citations

This map shows the geographic impact of Sandra Cantilena's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Cantilena with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Cantilena more than expected).

Fields of papers citing papers by Sandra Cantilena

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Cantilena. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Cantilena. The network helps show where Sandra Cantilena may publish in the future.

Co-authorship network of co-authors of Sandra Cantilena

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Cantilena. A scholar is included among the top collaborators of Sandra Cantilena based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Cantilena. Sandra Cantilena is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Cantilena, Sandra, et al.. (2024). Synergistic Strategies for KMT2A-Rearranged Leukemias: Beyond Menin Inhibitor. Cancers. 16(23). 4017–4017. 2 indexed citations
2.
Xiao, Lin, Sandra Cantilena, Anna Mariana, et al.. (2024). FDA-approved disulfiram as a novel treatment for aggressive leukemia. Journal of Molecular Medicine. 102(4). 507–519. 7 indexed citations
3.
Gasparoli, Luca, Clémence Virely, Sandra Cantilena, et al.. (2022). Identification of a c-MYB-directed therapeutic for acute myeloid leukemia. Leukemia. 36(6). 1541–1549. 19 indexed citations
4.
Cantilena, Sandra, Luca Gasparoli, Deepali Pal, et al.. (2022). Direct targeted therapy for MLL‐fusion‐driven high‐risk acute leukaemias. Clinical and Translational Medicine. 12(6). e933–e933. 8 indexed citations
5.
Meier, Stefanie L., Sandra Cantilena, Maria Victoria Niklison-Chirou, et al.. (2021). Alcohol-abuse drug disulfiram targets pediatric glioma via MLL degradation. Cell Death and Disease. 12(8). 785–785. 13 indexed citations
6.
Cantilena, Sandra, Nicholas Goulden, Owen Williams, & Jasper de Boer. (2015). Drug Induced MLL Fusion Degradation Via Hsp90 Inhibition. Blood. 126(23). 4850–4850. 1 indexed citations
7.
Corvetta, Daisy, Olesya Chayka, Samuele Gherardi, et al.. (2013). Physical Interaction between MYCN Oncogene and Polycomb Repressive Complex 2 (PRC2) in Neuroblastoma. Journal of Biological Chemistry. 288(12). 8332–8341. 64 indexed citations
8.
Santilli, Giorgia, Izabela Piotrowska, Sandra Cantilena, et al.. (2013). Polyphenol E Enhances the Antitumor Immune Response in Neuroblastoma by Inactivating Myeloid Suppressor Cells. Clinical Cancer Research. 19(5). 1116–1125. 66 indexed citations
9.
Cantilena, Sandra, et al.. (2012). A chemical screen identifies the chemotherapeutic drug topotecan as a specific inhibitor of the B-MYB/MYCN axis in neuroblastoma. Oncotarget. 3(5). 535–545. 17 indexed citations
10.
Cantilena, Sandra, Fabio Pastorino, Annalisa Pezzolo, et al.. (2011). Frizzled receptor 6 marks rare, highly tumourigenic stem-like cells in mouse and human neuroblastomas. Oncotarget. 2(12). 976–983. 64 indexed citations
11.
Gualdrini, Francesco, Daisy Corvetta, Sandra Cantilena, et al.. (2010). Addiction of MYCN Amplified Tumours to B-MYB Underscores a Reciprocal Regulatory Loop. Oncotarget. 1(4). 278–288. 28 indexed citations
12.
Lanuti, Paola, Marco Marchisio, Sandra Cantilena, et al.. (2006). A flow cytometry procedure for simultaneous characterization of cell DNA content and expression of intracellular protein kinase C-ζ. Journal of Immunological Methods. 315(1-2). 37–48. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026